Carmot Therapeutics, Inc.

This study tested a new medicine called CT-868 in 103 overweight or obese adults with type 2 diabetes. The goal was to see if it could lower blood sugar levels and help with weight loss over 26 weeks. Participants received either the drug or a placebo, and researchers measured ch…

This study tested a new once-weekly injection called CT-388 (also known as enicepatide) to help people with obesity or overweight who also have related health problems like high blood pressure or prediabetes. About 469 adults took part, receiving either a low, middle, or high dos…

This early-stage study tested an experimental drug called CT-388 in 129 overweight or obese adults, some with type 2 diabetes. The goal was to check safety and how the drug affects body weight and blood sugar. Participants received either the drug or a placebo as a shot under the…